This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Yuuri Hashimoto
Oncology Research Laboratories I at Daiichi Sankyo Co.,Ltd.


Yuuri Hashimoto, PhD is a cancer biologist who has over 10 years of experience in translational cancer research. After receiving her PhD from Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, she subsequently completed her postdoctoral research at University of Texas MD Anderson Cancer Center. Her past work encompassed a variety of cancer research from characterization of solid tumors including patient samples to development of anticancer biological therapeutics. She has published more than 40 research articles in peer-reviewed journals. Dr. Hashimoto joined Daiichi Sankyo Co., Ltd. in 2018 and is currently working on antibody-drug conjugates in preclinical pharmacology and translational research team.

Agenda Sessions

  • Daiichi Sankyo (DS) ADC Platform and Preclinical and Clinical Updates on Its Application


Speakers at this event